Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Journal of Neurochemistry
|
March 1, 1987
Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists
W C Boyar, C A Altar
Brain Research
|
April 3, 1989
Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin
C A Altar, W C Boyar
European Journal of Pharmacology
|
February 24, 1987
Dopamine autoreceptor agonists including CGS 15855A decrease dopamine release and metabolism in mouse brain
C A Altar, W C Boyar, P L Wood
European Journal of Pharmacology
|
May 31, 1990
Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP
C A Altar, W C Boyar, H S Kim
Brain Research
|
April 30, 1986
125I-LSD autoradiography confirms the preferential localization of caudate-putamen S2 receptors to the caudal (peripallidal) region
C A Altar, W C Boyar, M R Marien
Neuropharmacology
|
January 1, 1989
Inhibition of nigrostriatal release of dopamine in the rat by adenosine receptor agonists: A1 receptor mediation
P L Wood, H S Kim, W C Boyar, et al.
Neuropharmacology
|
October 1, 1987
Injections of deuterated tryptamine into the nucleus accumbens of the rat: effects on locomotor activity and monoamine metabolism
M R Marien, R Gerber, W C Boyar, et al.
Brain Research
|
September 13, 1988
Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release
C A Altar, W C Boyar, E Oei, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1987
Dopamine autoreceptors modulate the in vivo release of dopamine in the frontal, cingulate and entorhinal cortices
C A Altar, W C Boyar, E Oei, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 8, 1998
Characterization of human PLD2 and the analysis of PLD isoform splice variants
P M Steed, K L Clark, W C Boyar, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Journal of Neurochemistry
|
March 1, 1987
Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists
W C Boyar, C A Altar
Brain Research
|
April 3, 1989
Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin
C A Altar, W C Boyar
European Journal of Pharmacology
|
February 24, 1987
Dopamine autoreceptor agonists including CGS 15855A decrease dopamine release and metabolism in mouse brain
C A Altar, W C Boyar, P L Wood
European Journal of Pharmacology
|
May 31, 1990
Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP
C A Altar, W C Boyar, H S Kim
Brain Research
|
April 30, 1986
125I-LSD autoradiography confirms the preferential localization of caudate-putamen S2 receptors to the caudal (peripallidal) region
C A Altar, W C Boyar, M R Marien
Neuropharmacology
|
January 1, 1989
Inhibition of nigrostriatal release of dopamine in the rat by adenosine receptor agonists: A1 receptor mediation
P L Wood, H S Kim, W C Boyar, et al.
Neuropharmacology
|
October 1, 1987
Injections of deuterated tryptamine into the nucleus accumbens of the rat: effects on locomotor activity and monoamine metabolism
M R Marien, R Gerber, W C Boyar, et al.
Brain Research
|
September 13, 1988
Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release
C A Altar, W C Boyar, E Oei, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1987
Dopamine autoreceptors modulate the in vivo release of dopamine in the frontal, cingulate and entorhinal cortices
C A Altar, W C Boyar, E Oei, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 8, 1998
Characterization of human PLD2 and the analysis of PLD isoform splice variants
P M Steed, K L Clark, W C Boyar, et al.
Page
of 2